Evidence map›Paper›PMID 42255785›Full record

ArticleCureus2026

Benign-Appearing Palmar Lesion in a Young Woman: The Importance of Considering Digital Papillary Adenocarcinoma.

Eva Cannaferina, Mathias Rouveyrol, Audrey Michot, Lucie Peuvrel, Ludovic Ardouin

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Eva CannaferinaPlastic Surgery, Hand Surgery, Centre Hospitalier Universitaire (CHU) de Bordeaux, Bordeaux, FRA.
Mathias RouveyrolHand Surgery Department, Clinique Mutualiste de Bretagne Occidentale, Quimper, FRA.
Audrey MichotReconstructive and Oncologic Department, Bergonié Institute, Bordeaux, FRA.
Lucie PeuvrelDermatology Department, Institut de Cancérologie de l'Ouest (ICO) Cancer Center, Saint Herblain, FRA.
Ludovic ArdouinHand Surgery Department, Institut de la main Nantes-Atlantique, Saint-Herblain, FRA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adnexal tumors are rare skin tumors, representing less than one percent of cutaneous cancers, with diagnosis and management remaining complex due to the absence of a consensual clinical, histological, and prognostic classification.  Among them, digital papillary adenocarcinoma is an exceptional malignant eccrine tumor responsible for local recurrences and metastatic dissemination. Its clinical presentation is nonspecific, which can lead to diagnostic delays. Classically described in middle-aged men and localized on the fingers, it can nevertheless present under misleading clinical and topographical forms. We report the atypical case of a 22-year-old female patient who, since childhood, had a painless palmar lesion that later became sensitive and was initially interpreted as a benign lesion. The diagnosis was only made after excision and histological confirmation following a review by the national Rare Cancers in Dermatology network (CARADERM). Management involved surgical re-excision with exhaustive analysis of margins using the Slow-Mohs technique combined with sentinel lymph node biopsy, without evidence of residual tumor. After a prolonged follow-up of 79 months, no local or distant recurrence was observed. This case highlights the importance for hand surgeons to be aware of this type of tumor and for pathologists to rely on a double review by the national network in cases of clinico-pathological doubt to optimize diagnosis and management.

Indexed as

adnexal tumorscaradermdigital papillary adenocarcinomahpv-42slow-mohs

Identifiers

PMID42255785
PMCPMC13238179

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.